ArticleBJR artificial intelligence2026
Aligning brain tumor imaging: generating synthetic 3D FA maps from T1-weighted MRI using CycleGAN models.
Article in BJR artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study addresses the issue of spatial misalignment between fractional anisotropy (FA) maps and tractography atlases in neuroimaging. We propose a CycleGAN-based method to generate FA and directionally encoded color (DEC) maps directly from T1-weighted MRI scans, applicable to both healthy and tumor-affected cases. Methods: A CycleGAN model was developed and trained using unpaired data to convert T1-weighted MRI images into FA and DEC maps. The quality of the generated maps was assessed using Structural Similarity Index (SSIM) and Peak Signal-to-Noise Ratio (PSNR) metrics. Special emphasis was placed on evaluating performance in tumor regions. Radiological assessments were also conducted to determine the clinical applicability of the generated maps. Results: The CycleGAN-based model effectively generated high-fidelity FA and DEC maps, with robust SSIM and PSNR values, particularly in tumor regions. Radiological evaluations highlighted the potential of this approach to enhance clinical workflows, offering a reliable AI-driven alternative to traditional image processing methods. Conclusions: This CycleGAN-based approach successfully mitigates the problem of spatial misalignment by generating accurate FA and DEC maps from T1-weighted MRI scans. The method offers a promising pathway for integrating assessments of white matter integrity into predictive models without requiring additional imaging. Advances in knowledge: This study introduces the first use of CycleGAN for generating FA and DEC maps from T1-weighted images for tumor-affected cases, presenting a method that could enhance neuroimaging procedures by reducing the need for additional scans and improving efficiency in clinical settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.